| HOME
|
Transplant Articles
(Back to main transplant page)
A great Source of Information
CIRRHOSIS,
TRANSPLANTS & BEYOND
| OCT 2004 |
Page Twenty One
Hepatitis C
recurrence after liver transplantation New Liver Rejection Treatment Approach Demonstrates Its Merit, Doctors Say Oct 01 2004 Docs Zero In on HCV Re-Infection After Transplant Oct 01 2004 New Drug Combination Cuts Rejection, May Combat HCV Oct 01 2004 |
| July 2004 |
Page Nineteen |
|
|
| April 2004 | Page Sixteen |
|
| Treatment of Recurrent Hepatitis C After Liver Transplantation: A Pilot Study of Peginterferon Alfa-2b and Ribavirin | ||
| New Onset Diabetes Mellitus After Liver Transplantation: The Critical Role of Hepatitis C Infection | ||
Editorial Changing
faces natural
course and treatment of hepatitis C after liver transplantation |
||
| HCV Disease Recurrence is Earlier and More Severe in Living Donor Liver Transplantation (LDLT) Compared to Cadaveric Transplantation | ||
| Low-dose Ribavirin Monotherapy Is Well Tolerated in Transplant Recipients with Recurrent HCV Disease and Is Associated with a Significant Delay in Fibrosis Progression |
| Mar 2004 |
Page
Fifteen
Information About Organ Transplants in China (Americans going to China for transplants) |
|
|
Severe hepatitis C-related liver damage following
liver transplantation
|
| Feb 2004 | Page Fourteen | |
| A National Survey of Split-Liver Transplantation in the United States | ||
| Clinical Trials: Hepatic Encephalopathy | ||
| How Does Combo Therapy Stack Up Against Recurrent Hepatitis? | ||
| Liver transplantation in patients with liver cirrhosis and esophageal bleeding. | ||
| Jan 2004 | Page Thirteen 2004 Articles |
|
|
Treatment considerations in patients with hepatitis C
and cirrhosis |
||
| The Second Time Around: Retransplantation for Recurrent Hepatitis C | ||
| Pilot Study of Pegylated Interferon Alfa-2b and Ribavirin for Recurrent Hepatitis C After Liver Transplantation | ||
|
Doctors Urge Pre-Transplant Liver Screenings to Avoid
Complications Later Page Twelve |
||
| Oct 2003 | Idun Pharmaceuticals Initiates Phase 2 Clinical Trial In Liver Transplantation | |
|
Branched-Chain
Amino Acids Effective Treatment for Cirrhosis |
||
| Poor survival after liver retransplantation: Is hepatitis C to blame? | ||
| Adult to Adult Living Donor Liver Transplantation Cohort Study | ||
|
Hepatitis C
Positive Grafts may Be Used in Orthotopic Liver Transplantation: A Matched Analysis |
| Sep 2003 | Page Eleven | |
| Treatment of Recurrent HCV after Liver Transplantation | ||
| Preventive Treatment for HCV Recurrence in Patients with Decompensated Post-hepatitis C Cirrhosis Before Liver Transplantation: An Editorial | ||
| Kidney Failure a Major Problem in Transplants | ||
| Factors influencing the outcome of liver retransplantation |
| Aug 2003 | Treatment of HCV Patients Awaiting Liver Transplantation Helps to Prevent HCV Recurrence Following Surgery | |
|
Antiviral
therapy of patients for patients awaiting liver transplantation: A strategy to prevent hepatitis C recurrence after transplantation |
||
| Reversal of cirrhosis: evidence-based medicine? | ||
| Immunosuppressive Drugs and the Use of Generic Immunosuppressants |
|
Liver
Transplantation ( Great Article) Page Ten |
||
| Antiviral Therapy Has Long-Term Benefits for Liver Recipients With Recurrent HCV | ||
| Outcome of liver transplantation for patients infected by hepatitis C Genotype 4 | ||
| Immune System Drug May Increase Availability of Liver Transplants | ||
| A Model to Predict Severe HCV-Related Disease Following Liver Transplantation | ||
| IL-6: A magic potion for liver transplantation? | ||
|
Highlights of the 9th Meeting of the International
Liver Transplantation Society Page Nine |
| Advancing Age of Liver Donors Has Powerful Effect on Survival of Transplant Recipients | ||
| Pediatric Issues in New Therapies for Hepatitis C and B | ||
| Pilot Study of Interferon Alfa and Ribavirin in Liver Transplant Recipients with Recurrent Hepatitis C | ||
| Preventative Therapy Prior to Transplant May Help Increase Survival | ||
| Half of Cirrhosis Patients Respond to Pegasys and Ribavirin | ||
|
Hepatitis C
Recurrence is Generally Mild After Transplantation, Austrian Investigators
Report |
| May-July 2003 | Consensus Development Symposium Focuses on Recurrent HCV Infection Following Liver Transplantation |
| Jan-Mar 2003
|
Better Matching Tests, Better Outcomes for Liver Transplants ? | |
| An artificial liver may bridge a gap ? | ||
| Pilot Study of Treatment with PEG-Intron (peginterferon alfa-2b) and Ribavirin in Liver Transplant Patients with HCV Infection | ||
| PEG-Intron Plus Ribavirin Is Effective for Hepatitis C Recurrence in Treatment-naïve Liver Transplant Recipients | ||
| PEG-Intron Plus Ribavirin in Liver Transplant Patients with Recurrent HCV Non Responsive to Rebetron | ||
| Efficacy of PEG-Intron Plus Ribavirin in Treatment-Naïve Patients with Recurrent HCV After Liver Transplantation | ||
|
Organ Transplant
Success Improves With Male Donors, Study Suggests |
||
|
Recurrence of
Hepaitis C in Transplants
Page Eight
2002 Articles Page Seven NIH Launches Study of Living Donor Liver Transplantation Potential Therapy Reported for Children, Adults with End-Stage Liver Disease Acute liver failure and timing of transplantation New Model Identifies Patients With Best Chance of Surviving Liver Transplant Potential Therapy Reported for Children, Adults with End-Stage Liver Disease
|
Two Great Forums to visit
http://forums.delphiforums.com/livertransplant/start
http://forums.delphiforums.com/liverfailure
|
Reviewed on June 04 2004